🇺🇸 FDA
Patent

US 11390646

Structure-based peptide inhibitors of α-synuclein aggregation

granted A61KA61K38/00A61P

Quick answer

US patent 11390646 (Structure-based peptide inhibitors of α-synuclein aggregation) held by The Regents of the University of California expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P25/16